Exhibit 99.1 Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update Quarter highlighted by the key acquisition of The Sleep Center of Nevada, which is generating revenue and seeing strong patient demand for Vivos' dif erentiated array of highly ef ective OSA treatments Management to Host Conference Call today at 5:00 pm ET LITTLETON, Colo., August 19, 2025 – Vivos Therapeutics, Inc. ("Vivos" or the "Company'') (NASDAQ: VVOS), a leading medical device and technology ...